No Long-Term Cognitive Effects Seen for Menopausal Hormone Therapy
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Nov. 22, 2024 -- Menopausal hormone therapy (mHT) is not associated with long-term cognitive effects versus placebo, according to a study published online Nov. 21 in PLOS Medicine.
Carey E. Gleason, Ph.D., from the University of Wisconsin in Madison, and colleagues examined the long-term effects of mHT initiated in early menopause in participants enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)-Cog trial and its parent study (KEEPS), in which women were randomly assigned to transdermal estradiol, oral conjugated equine estrogens, or placebo during early menopause. The KEEPS Continuation observational longitudinal cohort study involved recontacting KEEPS participants about 10 years after completion of the four-year clinical trial. For 275 participants, cognitive data from both KEEPS and KEEPS Continuation were available.
The researchers observed significant associations between intercepts and slopes for cognitive performance across almost all domains in latent growth models, indicating a change in cognitive factor scores over time. Tests examining the effects of mHT allocation on cognitive slopes were statistically nonsignificant during KEEPS and across all years of follow-up. No long-term cognitive effects of mHT were seen in the KEEPS Continuation study, with baseline cognition and changes during KEEPS being the strongest predictors of later performance. About 10 years after completion of the randomized treatments, participants assigned to mHT in KEEPS performed similarly on cognitive measures to those assigned to placebo.
"The KEEPS Continuation findings extend our understanding of the cognitive effects of mHT beyond short-term effects; specifically, use of hormone therapy within the time frame of early menopause appears to have no long-term cognitive effects," the authors write.
Two authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-24 00:00
Read more
- AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designations for AB-1003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9
- Palleon Pharmaceuticals Presents Results from the Phase 1/2 GLIMMER-01 Trial of E-602 in Combination with Cemiplimab in Patients with Solid Tumors at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
- Trends in Obesity Treatment Show Surge in GLP-1 RAs, Drop in Surgeries
- Big Post-Election Surge Seen in Online Sales of Morning-After Pills
- Monthly News Roundup - October 2024
- Iowa Resident Dies of Suspected Lassa Fever After Trip to West Africa
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions